Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Mitsui Chemicals, Inc. (4183.T)
Tokyo, JP
Mitsui Chemicals, Inc. is a diversified chemical enterprise operating across key sectors including mobility, healthcare, food and packaging, and basic materials. Within its Mobility division, it develops and supplies elastomers, various performance compounds, and functional polymers primarily for automotive and industrial applications, alongside offering related development services. The Health Care segment furnishes materials for optical products, nonwovens, dental procedures, and general personal care. Its Food and Packaging unit delivers specialized coating and engineering materials, high-performance films and sheets, and agrochemical solutions. The Basic Materials division is a significant producer of foundational chemicals such as ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid (PTA), PET, and polyurethane intermediates, in addition to other industrial chemicals. Beyond these core areas, Mitsui Chemicals' extensive product portfolio extends to civil engineering and construction materials, cosmetic ingredients, various adhesives (for wood and paper), foliar activators, a broad range of polyolefin and urethane resins and films, injection molding equipment, phosphoric acid, and fertilizers. Further offerings include spunbonded nonwoven fabrics, synthetic fibers, monomers for optical lenses, and a variety of fine and inorganic chemicals. The company also provides comprehensive technical services, encompassing performance analysis, physical property measurements, and safety evaluations for chemicals. Furthermore, its ancillary operations include personnel placement, temporary staffing, insurance and travel services, consignment business, and the sale of electronics and information technology materials. Mitsui Chemicals maintains a robust global sales network, serving markets in Japan, China, the wider Asian region, the Americas, and Europe. The company was established in Tokyo, Japan, in 1892, where it continues to maintain its corporate headquarters.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.42% | +12.72% | +10.81% | -8.77% | +21.06% | +6.91% | +38.10% | +22.99% | +20.08% | +137.20% | +7.79% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | 0 |
| Hold | 4 | 0 |
| Sell | 1 | +1 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-7.8% Q1'26: -4.3% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+7.4% Q1'26: +316.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+5.5% Q1'26: +8.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+5.2% Q1'26: +6.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+3.8% Q1'26: +6.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.8% ★ Q1'26: -0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.88× Q1'26: 3.27× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 11 Rev. Ana. 11 EPS Ana. |
Mar 2027 11 Rev. Ana. 11 EPS Ana. |
Mar 2028 10 Rev. Ana. 10 EPS Ana. |
Mar 2029 2 Rev. Ana. 2 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.55T
est: 1.56T (-0.9%)
|
1.34T
est: 1.36T (-1.0%)
|
1.21T
est: 1.18T (+2.5%)
|
1.33T
est: 1.34T (-0.5%)
|
1.48T
est: 1.49T (-0.6%)
|
1.35T
est: 1.35T (+0.3%)
|
1.21T
est: 1.20T (+0.9%)
|
1.61T
est: 1.61T (+0.1%)
|
1.88T
est: 1.91T (-1.6%)
|
1.75T
est: 1.79T (-2.3%)
|
1.81T
est: 1.82T (-0.3%)
|
1.67T
1.65T – 1.70T
-8.0% YoY
|
1.76T
1.66T – 1.89T
+5.2% YoY
|
1.82T
1.73T – 1.93T
+3.5% YoY
|
1.96T
1.86T – 2.10T
+7.8% YoY
|
2.05T
1.94T – 2.20T
+4.6% YoY
|
| EBITDA |
90.29B
est: 176.32B (-48.8%)
|
119.57B
est: 152.97B (-21.8%)
|
144.84B
est: 133.35B (+8.6%)
|
149.15B
est: 150.56B (-0.9%)
|
142.93B
est: 168.18B (-15.0%)
|
145.10B
est: 151.67B (-4.3%)
|
155.92B
est: 135.37B (+15.2%)
|
216.30B
est: 181.62B (+19.1%)
|
181.19B
est: 215.25B (-15.8%)
|
180.62B
est: 203.87B (-11.4%)
|
192.92B
est: 206.58B (-6.6%)
|
189.97B
187.35B – 193.20B
-8.0% YoY
|
199.90B
188.94B – 215.61B
+5.2% YoY
|
206.92B
196.33B – 220.09B
+3.5% YoY
|
222.98B
211.17B – 238.80B
+7.8% YoY
|
233.33B
220.97B – 249.89B
+4.6% YoY
|
| EBIT |
42.04B
est: 90.58B (-53.6%)
|
70.93B
est: 78.59B (-9.8%)
|
100.78B
est: 68.51B (+47.1%)
|
103.49B
est: 77.35B (+33.8%)
|
93.43B
est: 86.40B (+8.1%)
|
69.09B
est: 77.92B (-11.3%)
|
79.30B
est: 69.55B (+14.0%)
|
132.07B
est: 93.31B (+41.5%)
|
89.11B
est: 110.59B (-19.4%)
|
85.37B
est: 105.70B (-19.2%)
|
93.15B
est: 107.10B (-13.0%)
|
98.49B
97.13B – 100.17B
-8.0% YoY
|
103.64B
97.96B – 111.78B
+5.2% YoY
|
107.28B
101.79B – 114.10B
+3.5% YoY
|
115.60B
109.48B – 123.81B
+7.8% YoY
|
120.97B
114.56B – 129.55B
+4.6% YoY
|
| Net Income |
17.26B
est: 16.05B (+7.6%)
|
22.96B
est: 32.07B (-28.4%)
|
64.84B
est: 55.39B (+17.1%)
|
71.59B
est: 72.45B (-1.2%)
|
76.12B
est: 74.44B (+2.2%)
|
33.97B
est: 44.80B (-24.2%)
|
57.87B
est: 48.13B (+20.2%)
|
109.99B
est: 103.42B (+6.4%)
|
82.94B
est: 94.28B (-12.0%)
|
50.00B
est: 117.28B (-57.4%)
|
32.24B
est: 55.06B (-41.4%)
|
42.21B
32.72B – 53.86B
-23.3% YoY
|
57.85B
45.97B – 80.77B
+37.1% YoY
|
74.14B
62.53B – 96.68B
+28.2% YoY
|
86.55B
84.80B – 98.56B
+16.7% YoY
|
105.37B
98.11B – 115.09B
+21.7% YoY
|
| SGA |
167.10B
est: 221.87B (-24.7%)
|
172.03B
est: 192.50B (-10.6%)
|
161.46B
est: 167.80B (-3.8%)
|
172.50B
est: 189.46B (-9.0%)
|
187.11B
est: 211.63B (-11.6%)
|
193.21B
est: 190.85B (+1.2%)
|
180.74B
est: 170.35B (+6.1%)
|
208.54B
est: 228.54B (-8.8%)
|
249.43B
est: 270.86B (-7.9%)
|
240.73B
est: 242.46B (-0.7%)
|
231.58B
est: 245.68B (-5.7%)
|
225.92B
222.81B – 229.77B
-8.0% YoY
|
237.73B
224.70B – 256.42B
+5.2% YoY
|
246.09B
233.49B – 261.74B
+3.5% YoY
|
265.18B
251.13B – 284.00B
+7.8% YoY
|
277.49B
262.79B – 297.18B
+4.6% YoY
|
| EPS |
43.10
est: 84.89 (-49.2%)
|
57.38
est: 169.64 (-66.2%)
|
162.03
est: 293.03 (-44.7%)
|
179.19
est: 383.28 (-53.2%)
|
192.80
est: 393.80 (-51.0%)
|
87.26
est: 236.97 (-63.2%)
|
149.00
est: 254.61 (-41.5%)
|
282.73
est: 547.10 (-48.3%)
|
215.59
est: 498.12 (-56.7%)
|
131.49
est: 306.60 (-57.1%)
|
85.28
est: 143.94 (-40.8%)
|
111.51
86.55 – 142.47
-22.5% YoY
|
154.50
121.60 – 213.64
+38.5% YoY
|
200.41
165.40 – 255.71
+29.7% YoY
|
242.50
224.30 – 260.70
+21.0% YoY
|
278.70
259.51 – 304.42
+14.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Lazard Japanese Equity ETF JPY | 0.49% | 372.5K | 0.60% |
| 2 | Amundi MSCI New Energy UCITS ETF Dist NRJU.L | 0.47% | 5.91M | 0.60% |
| 3 | Sparkline International Intangible Value ETF DTAN | 0.36% | 52.7K | 0.55% |
| 4 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.34% | 1.93M | 0.58% |
| 5 | iShares MSCI Japan Small-Cap ETF SCJ | 0.34% | 871.0K | 0.50% |
| 6 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD dis WSCR.L | 0.18% | 1.42M | 0.23% |
| 7 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD acc WSCSRI.SW | 0.18% | 1.42M | 0.23% |
| 8 | WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc DXJD.SW | 0.17% | 1.75M | 0.45% |
| 9 | WisdomTree Japan Equity UCITS ETF DXJ.L | 0.17% | 1.42M | 0.48% |
| 10 | WisdomTree Japan Equity UCITS ETF - GBP Hedged DXJP.L | 0.17% | 1.90M | 0.45% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Satoshi Ichimura | President, Chief Executive Officer & Representative Director | 115M | male |
| Osamu Hashimoto | President, Chief Executive Officer & Representative Director | 115M | male |
| Atsushi Komoriya | Managing Executive Officer & President of Mobility Solutions Business Sector | — | — |
| Kazumasa Izawa | Senior Managing Executive Officer & President of Basic & Green Materials Business Sector | — | — |
| Ken Migita | CHRO & Managing Executive Officer | — | — |
| Masao Sambe | Managing Executive Officer, CDO & President of Digital Transformation Sector | — | — |
| Mitsutoshi Maeda | Executive Officer and GM of Corporate Administration & Legal Division | — | — |
| Osamu Yoshida | Managing Executive Officer & Chief Financial Officer | — | — |
| Shingo Shibata | Managing Executive Officer and Center Executive of R&D Center | — | male |
| Taro Koike | Director of IR Department - Corporate Communicate Division | — | male |
| Toshihiko Omote | Managing Executive Officer & Chief Technology Officer | — | — |
| Toshiya Urakawa | Executive Officer & Senior Vice President of Digital Transformation Sector | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4183.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
